. Sequence conservation of MIR30A, tested backbone variants, reporter assay for shRNA validation, and structure of miR-E. Related to Figure 1 . Sequence information on the conservation of the endogenous MIR30A, and on sequence variants of synthetic miRNA backbones tested. Also included is information on an RNAi reporter assay used to assess shRNAmir efficiency. Figure 3 . Analysis of the presence or absence of NCNNC motifs in the 3' and 5' flanks of endogenous human miRNAs, and their correlation with miRNA abundance. Also included is an analysis of synthetic shRNAmir processing efficiency and its impact on viral packaging as well as synthetic pri-miRNA levels.
Supplemental Information Inventory Figure S1 . Sequence conservation of MIR30A, tested backbone variants, reporter assay for shRNA validation, and structure of miR-E. Related to Figure 1 . Sequence information on the conservation of the endogenous MIR30A, and on sequence variants of synthetic miRNA backbones tested. Also included is information on an RNAi reporter assay used to assess shRNAmir efficiency. 
Figure S1
MicroRNA-30a conservation:
1) Human (hg19) 2) Chimp (panTro2) 3) Rhesus (rheMac2) 4) Dog (canFam2) 5) Elephant (loxAfr3) 6) Mouse (mm9) 7) Rat (rn4) 8) Opossum (monDom5) 9) Chicken (galGal3) Figure S1 (continued) Typically, a DNA fragment containing up to 20 shRNA target sites is generated using gene synthesis (e.g. gBlocks Gene Fragments, IDT), and introduced using directional cloning.
(D) Schematic depicting the experimental workflow of a reporter assay (up to 20 shRNAs can be evaluated in a single round). A TtNPT vector containing control and experimental shRNA target sites is transduced into reporter cells (typically rtTA expressing mouse or chicken embryonic fibroblasts) using amphotropic (or VSV-G pseudotyped) packaging (to keep reporter cells naive to ecotropic transduction). Following selection using doxycyline (dox) and G418 and/or FACS, dTomato positive reporter cells are infected at single-copy with individual control and experimental shRNAs expressed from any shRNAmir expression vector co-expressing GFP (e.g. LMP, LMN, LEPG, LENG).
(E) Flow cytometry based analysis of reporter cells at different stages of the assay. The graphs show dot blots and histograms of the same cell populations. dTomato levels are quantified (typically 3 and 6 days after infection), and compared between shRNA expressing (GFP + ) and shRNA negative (GFP -) cells.
As final readout, the relative reporter knockdown is calculated for each sample, and compared to included controls of known knockdown potency.
(F) Side-by-side comparison of knockdown potencies of a set of Dnmt3a shRNAs determined using the reporter assay or western blotting in NIH3T3 cells expressing Flag-tagged Dnmt3a. Western blot signal intensities were normalized to β-Actin, and the knockdown level quantified relative to the empty vector control. Knockdown levels determined by western blotting and the reporter assay correlate strongly (Pearson r = 0.87, p<0.001), illustrating that the reporter assay provides an accurate surrogate assay to assess single-copy shRNA knockdown potencies in a standardized and scalable way. Asterisk, Dnmt3a.745 shRNA was not analyzed in this reporter assay, but later evaluated in an independent reporter experiment (see Figure 2F ).
(G) Schematic showing the structure of the conventional miR-30 (for reference, see also Figure 1A ) and miR-E backbones. In miR-E, nucleotides that are altered compared to miR-30 are shown in orange. The guide strand is highlighted in yellow. The XhoI (CTCGAG) and EcoRI (GAATTC) restriction sites, as well as an adapted region in the 5' flank are marked in blue. A conserved sequence region 3' of the basal stem is underlined. The locations of the basal stem, stem and loop are indicated. (F) Flow cytometry plots showing the effects of three selected Dnmt3a shRNAs in the miR-30 and miR-E format, which were analyzed using the same reporter assay as in (E). In all three cases the miR-E design enhances reporter knockdown. (D) Functional quantification of pri-miRNA transcript levels in HeLa cells co-transfected with a dualcolor vector expressing the indicated miR-30 or miR-E based shRNA and siRNAs targeting DGCR8, DROSHA or firefly luciferase as control. The schematic depicts the configuration of the dual-color vector pPGmC expressing GFP-coupled shRNAmirs from a PGK-driven transcript, while mCherry and Blasticidin S (BlaS) are expressed from an independent transcript driven by EF1α-short (EF1αs). The data shows normalized mean fluorescence intensity ratios of GFP compared to mCherry. Error bars indicate the SEM. Table S1 . shRNA sequences. Related to Figure 1 and 2.
97-mer sequences of all shRNAs used in this study. Sensor-based shRNA predictions for all human and mouse coding genes. Provided are the ten topranked shRNAs predicted to target all transcript variants known at the time of design (95 human or mouse genes had less than ten predictions that passed our minimum scoring threshold). For each entry, the spreadsheet contains the Entrez Gene ID, Gene Symbol, Species, shRNA ID, Rank, Guide strand, mRNA target site, and the 97-mer oligonucleotide for direct cloning into the miR-E backbone.
Supplemental Experimental Procedures
Vectors, backbone and shRNA cloning
The miR-E backbone and all variants were constructed according to the sequences provided ( Figure  S1B ), using custom oligonucleotides (IDT) and standard cloning techniques. Retroviral vectors ( Figure  S4C ) were constructed based on existing miR-30 shRNA expression vectors in pMSCV or pQCXIX backbones Zuber et al., 2011a; Zuber et al., 2011b) . Lentiviral vectors ( Figure S4D ) were constructed in the pRRL backbone (Dull et al., 1998 ) based on derivatives of pRRL.PPT.SF.GFPpre (Schambach et al., 2006) , kindly provided by A. Schwarzer and A. Schambach. Existing miR-30 shRNAs were converted to miR-E by a simple PCR amplification using the primers miRE-Xho-short-fw (5'-AGAAGGCTCGAGAAGGTATATTGC-3') and miRE-EcoPlasmid-rev (5'-GCTCGAATTCTAGCCCCTTGAAGTCCGAGG-3'), 10 ng plasmid template, and the PfuUltra HF kit (Agilent Technologies). Amplification products were then XhoI/EcoRI cloned into recipient vectors using standard techniques. For de-novo generation of miR-E shRNAs, 97-mer oligonucleotides (IDT) coding for the respective shRNAs (Table S1) were PCR amplified using the primers miRE-Xho-fw (5'-TGAACTCGAGAAGGTATATTGCTGTTGACAGTGAGCG-3') and miRE-EcoOligo-rev (5'-TCTCGAATTCTAGCCCCTTGAAGTCCGAGGCAGTAGGC-3'), 0.05 ng oligonucleotide template, and the PfuUltra HF kit (Agilent Technologies). Following amplification, final vectors were obtained by XhoI/EcoRI cloning of the 125 nt shRNA fragments into recipient vectors featuring the miRE backbone. Both types of PCRs were run as 50 μl reactions containing 5 μl 10x PCR buffer, 1 μl dNTP (10 mM each), 2 μl primer mix (10 μM each), and 1 μl DNA polymerase. Cycling parameters were 95°C for 5 min; 30 cycles of 95°C for 25 s, 56°C for 25 s, and 72°C for 30 s; 72°C for 5 min. Final vectors were control sequenced using the primer miRseq5 (5'-TGTTTGAATGAGGCTTCAGTAC-3') or MSCV5' (5'-CCCTTGAACCTCCTCGTTCGACC-3'). All shRNA expression vectors (including vector maps and sequences) are available upon request.
Sensor rules and shRNA design
For de-novo prediction of shRNAs, siRNA guide predictions targeting common regions of all known transcript variants (NCBI Gene, http://www.ncbi.nlm.nih.gov/gene/) were obtained using the DSIR algorithm (Vert et al., 2006) . DSIR-predicted guide strands were subsequently filtered using "Sensor rules" to enrich for predictions harboring sequence features associated with effective shRNAmir processing and potent knockdown . A complete list of up-to-date Sensor-based shRNA predictions for all human and mouse coding genes are provided in Table S3 . For each gene, we provide 97-mer oligonucleotides (for direct miR-E cloning) for the ten top-ranked shRNAs predicted to target all transcript variants known at the time of design.
Cell culture and reporter cell lines
The mouse cell lines NIH3T3, BNL CL.2 (ATCC), SVEC4-10 (ATCC), TCMK-1 (ATCC) and RRT MEF , human HeLa cells, as well as derivatives of the chicken embryonic fibroblast cell line DF-1 (ATCC), were cultured in Dulbecco's Modification of Eagle's Medium with 4.5 g/l glucose, Lglutamine and sodium pyruvate (DMEM, Corning), 10% fetal bovine serum (FBS), and 100 U/ml penicillin and 100 μg/ml streptomycin (100-Pen-Strep) at 37°C with 5% CO 2 . For retroviral packaging, various derivatives of the human HEK293T cell line were used, including Phoenix Eco/Ampho and PlatE/A/GP (Cell Biolabs), and cultured in DMEM (Corning) supplemented with 10% FBS and 100-PenStrep (as above) at 37°C with 5% CO 2 . Tet-ON competent derivatives of the human leukemia cell line MOLM-13 were grown in RPMI 1640 (Gibco, Life Technologies) supplemented with 20% FBS and 100-Pen-Strep at 37°C with 7.5% CO 2 . Tet-regulated shRNAs were induced at doxycycline concentrations of 1.0-2.0 μg/ml.
Retroviral transduction
Cells were transduced as previously described . In brief, for each calcium phosphate transfection, 10-15 μg plasmid DNA and 5 μg helper plasmid (Eco, Ampho, VSV-G) were used. Transduction efficiencies of retroviral constructs were measured 48 h post infection by flow cytometry (Guava Technologies). Unless otherwise stated, and for cells that can be infected up to nearly 100%, single-copy conditions were achieved by infecting less than 20% of the initial population, guaranteeing <2% cells with multiple integrations . Transduced cell populations were generally selected 48 h post infection using 1.5-3.0 μg/ml puromycin (Sigma-Aldrich) or 500-2000 μg/ml G418 (Gibco, Life Technologies).
RNAi reporter assay for medium-throughput shRNA validation
This two-component reporter assay ( Figure S1C-F, S2D-F, S4A and B) provides a medium-throughput mean to functionally assess the efficiency of virtually any shRNA, and is composed of a reporter vector (TtNPT) and an shRNA expression vector (e.g. LEPG, LENG). The base reporter vector contains target sites for the control shRNAs Ren.713, Luci.1309 , Trp53.814, Bcl2.906, Pten.1523 and 1524 in the 3'UTR of the dTomato fluorescent reporter, as well as a XhoI/EcoRI multiple cloning site (directly downstream of the other target sites) for the insertion of further targets. To validate knockdown efficiency of experimental shRNAs, target linkers containing the 22 nt target sequence (+ ≥2 nt adjacent mRNA context on both sides) for each shRNA were designed (target sites may overlap). For cloning, XhoI and EcoRI restriction sites were added at the beginning and end of each target linker, respectively (with 2-6 nt overhangs for efficient cloning), while internal XhoI and EcoRI sites or poly(A) signals (AATAAA, ATTAAA) were removed. Final target linkers of up to 500 nt were ordered as double-stranded DNA (gBlocks, IDT), XhoI/EcoRI digested, ligated into XhoI/EcoRI cut and CIPed (CIP, NEB) TtNPT, and control sequenced using the primer dTomato-fw (5'-CCACCACCTGTTCCTGTACG-3') or SIN-rev (5'-TCTATGGCTCGTACTCTATAGGC-3').
